Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration

被引:137
作者
Gradolatto, A
Basly, JP
Berges, R
Teyssier, C
Chagnon, MC
Siess, MH
Canivenc-Lavier, MC
机构
[1] INRA, Unite Mixte Rech Toxicol Alimentaire, F-21065 Dijon, France
[2] Lab Chim Analyt & Bromatol, Unite Format & Rech Pharm, Limoges, France
关键词
D O I
10.1124/dmd.104.000893
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabolism of apigenin, a weak estrogenic flavonoid phytochemical, was investigated in the rat. After a single oral administration of radiolabeled apigenin, 51.0% of radioactivity was recovered in urine, 12.0% in feces, 1.2% in the blood, 0.4% in the kidneys, 9.4% in the intestine, 1.2% in the liver, and 24.8% in the rest of the body within 10 days. Sex differences appear with regard to the nature of compounds eliminated via the urinary route: immature male and female rats, like mature female rats, excreted a higher percentage of the mono-glucuronoconjugate of apigenin than the mono-sulfoconjugate of apigenin (10.0-31.6% versus 2.0-3.6%, respectively). Mature male rats excreted the same compounds in an inverse ratio (4.9% and 13.9%, respectively). Radioactivity appeared in the blood only 24 h after oral administration. Blood kinetics showed a high elimination half-time (91.8 h), a distribution volume of 259 ml, and a plasmatic clearance of 1.95 ml/h. All of the parameters calculated from these experiments suggested a slow metabolism of apigenin, with a slow absorption and a slow elimination phase. Thus, a possible accumulation of this flavonoid in the body can be hypothesized.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 35 条
  • [1] Bioavailability and metabolism of the flavonol quercetin in the pig
    Ader, P
    Wessmann, A
    Wolffram, S
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (07) : 1056 - 1067
  • [2] Identification of apigenin metabolites in rat liver perfusate by column switching high performance liquid chromatography/electrospray ionization mass spectrometry
    Basly, JP
    Gradolatto, A
    Teyssier, C
    Canivenc-Lavier, NC
    [J]. MONATSHEFTE FUR CHEMIE, 2003, 134 (03): : 355 - 359
  • [3] Dietary agents in cancer prevention: flavonoids and isoflavonoids
    Birt, DF
    Hendrich, S
    Wang, WQ
    [J]. PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) : 157 - 177
  • [4] BOUTIN JA, 1993, DRUG METAB DISPOS, V21, P1157
  • [5] Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability
    Breinholt, V
    Hossaini, A
    Svendsen, GW
    Brouwer, C
    Nielsen, SE
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2000, 38 (07) : 555 - 564
  • [6] COVA D, 1992, INT J CLIN PHARM TH, V30, P29
  • [7] DAI R, 1997, LIFE SCI, V61, P75
  • [8] Flavonoids: Old and new aspects of a class of natural therapeutic drugs
    Di Carlo, G
    Mascolo, N
    Izzo, AA
    Capasso, F
    [J]. LIFE SCIENCES, 1999, 65 (04) : 337 - 353
  • [9] Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver
    Gradolatto, A
    Canivenc-Lavier, MC
    Basly, JP
    Siess, MH
    Teyssier, C
    [J]. DRUG METABOLISM AND DISPOSITION, 2004, 32 (01) : 58 - 65
  • [10] Graefe EU, 1999, INT J CLIN PHARM TH, V37, P219